A review of the relevant manufacturing records for the involved device lot indicates that all aspects of manufacture, from initial processing through packaging and sterilization met all quality criteria for final release.A review of the sterilization records noted no abnormalities and all processing was within the required specification.A review of the complaint records indicates that there are no other similar events reported to date involving cartiva device lot f040518001.Patient information, additional details surrounding the removal intervention and the reported event as described were not made available for investigation.As a result, a patient impact assessment could be performed.At the present time, the event could not be definitely confirmed.Should additional details be provided in the future, an update to this submission will be provided.
|
Feedback received from implanting surgeon via their sales representative.According to the information received, a patient underwent a cartiva implant procedure on (b)(6)2018.Following, the implant was removed after an unspecified "injury to the foot" on (b)(6)2018, a month postoperative.The physician indicated to the sales representative that the device appeared "damaged" when it was removed.No additional information was made available.
|